ABT-773 full pharmacokinetic and pharmacodynamic profiles were elucidated in a murine pneumococcal lung infection model. Area under the curve divided by minimum inhibitory parameter to concentration was the best PK/PD 773. This drug was -predict efficacy of ABTeffective for both types of resistant level -level and high-pneumococcal strains, lowresistance.